3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
14
Prostatic Neoplasms
13
Colorectal Neoplasms
13
Neoplasms
12
Pancreatic Neoplasms
10
Endometrial Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Lung Neoplasms
7
Colonic Neoplasms
7
Neoplasm Metastasis
6
Carcinoma, Hepatocellular
6
Oropharyngeal Neoplasms
5
Multiple Myeloma
5
Mouth Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Sarcoma
4
Recurrence
4
Rectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Esophageal Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Interventions
Fluorouracil
41
Radiotherapy
38
Cisplatin
35
Oxaliplatin
32
Leucovorin
24
Paclitaxel
22
Irinotecan
20
Docetaxel
17
Neoadjuvant Therapy
14
Carboplatin
13
Radiation
12
Capecitabine
12
Surgical Procedures, Operative
10
Cetuximab
8
Biopsy
8
durvalumab
7
Gefitinib
7
Chemotherapy, Adjuvant
7
tremelimumab
6
pembrolizumab
6
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Folfox protocol
6
Taxes
5
Immunohistochemistry
5
Endoscopy
5
Gene Expression Profiling
4
Epirubicin
4
Drug Therapy
4
dehydroftorafur
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenocarcinoma Of Esophagus
×
Observation
×
Clear all
NCT06933966
2025-04-18
ATTENUATION
Centre Leon Berard
Phase 2
Not yet recruiting
120 enrolled